Skip to content

Effect of combination of Fruitflow and aspirin on platelet function and endothelial cells

Effect of combination of Fruitflow and aspirin on platelet function and endothelial cells

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034647
Enrollment
Unknown
Registered
2020-07-13
Start date
2019-02-18
Completion date
Unknown
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

Placebo group:placebo 150 mg/day
Fruitflow group:Fruitflow 150 mg/day
Aspirin group:Aspirin 100 mg/day
Fruitflow+Aspirin group:Fruitflow 150 mg/day+Aspirin 100 mg/day

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria adhered to the Chinese expert consensus on aspirin application guidelines. The subject has hypertension but his blood pressure is well controlled (<150/90 mmHg), or the subject has diabetes but his blood glucose is well controlled. The platelet aggregation rate of these subjects reached more than 50% in ADP- and collagen-activated platelets.

Exclusion criteria

Exclusion criteria: The exclusion criteria were blood pressure >=160/100 mmHg, platelet count < 100x10^9/L, prothrombin time outside the normal reference range, the chronic use of medications and nutritional supplements, allergy to tomatoes or their ingredients, intolerance or allergy to ASA, contraindications for ASA, and fecal occult blood positive test. Moreover, according to the researchers judgment, individuals with serious hematological diseases, digestive diseases, organic diseases of the heart, liver, or kidneys, severe liver or kidney dysfunction, or metabolic, endocrine, or nervous system diseases were also excluded

Design outcomes

Primary

MeasureTime frame
aggregation rate of platelet;Clotting function test;blood routine examination;biochemical test;blood pressure;Fecal occult blood test;

Secondary

MeasureTime frame
Height;Weight;

Countries

China

Contacts

Public ContactRuomei Qi

Beijing Hospital

ruomeiqi@163.com+86 10 58115047

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026